The Department of Pharmacy engages in pharmaceutical (pharmaceutics-related) free research as the basis for elevating areas of commitment to high, international levels and will facilitate research-based innovation.
Research within bacterial genome dynamics linked to pathogenicity and disease, biofilm formation, development of novel antimicrobials and antimicrobial resistance.
BioNatH is a research group in pharmacognosy. Our research has the goal to acquire new knowledge about natural products from sustainable medicinal plant and fungal resources and their potential to improve health.
The research group`s overarching goal is to study the effect of tailored drug therapy to the individual patient, on health outcomes. Our main focus is on patients with multiple long-term conditions and complex drug treatment.
Energy metabolism and new drug targets for therapy
The aim of the LIPCHEM group is to contribute to new knowledge on chronic inflammation. Chronic inflammation lies at the core of many diseases with a major impact on individuals and society. Thus, dealing with chronic, unresolved inflammation is at the forefront of contemporary medicine, health, and medicinal chemistry frontier. LIPCHEM is a part of the Medicinal Chemistry Group.
Research within microbial infections, microbiomes, vaccines and antimicrobial resistance in a One Health Perspective.
The Neurobiology and Toxicology group at the Department of Pharmacy studies the molecular mechanisms for cell death, cell survival, differentiation, and plasticity of the nervous system.
We aim to design new dosage forms and innovative technological solutions to fulfill the potential of personalized medicine for individuals or groups of individuals.
The research group in Pharmaceutical Analytical Chemistry develops new and sustainable technologies and concepts for pharmaceutical analysis and life sciences. Our main emphasis is to develop innovative solutions for isolating and extracting pharmaceuticals, endogenous substances, and diagnostic proteins from biological samples. We both test and develop our sustainable concepts for microextraction and micro-sampling using realistic settings.
We aim to understand how microorganisms contribute to our health and to the development of disease in a One Health perspective, and to contribute to the development of novel antimicrobial strategies for important human and animal pathogens. Studies are conducted at an organismic (host-microbe, microbiome), cellular and molecular level, and the research focuses on how changes and variability in microbial genomes affect cellular and viral processes, including resistance to antimicrobial agents, and how this knowledge may benefit society e.g. by contributing to the development of novel antimicrobial strategies including vaccine and diagnostic tools.
The research vision in the pharmacokinetics group is “ the right drug at the right dose to each patient”. We perform both basal and clinical research.
Formulation of photoreactive drugs and biological products.
The PharmaTox Strategic Research Initiative aims to generate novel insight on effects of pharmaceuticals on human neurotoxicity and neurodevelopment.
Before drugs and endogenous substances can be measured in biological samples, they have to be isolated from the original sample. In SamplePrep@UiO, we focus on development of new concepts for such isolation, based on microextraction.
The scientific aim of the group is to develop new site specific drug delivery systems and in addition acquire knowledge about basic mechanisms for controlling the site and the rate of drug release.
We focus on smart sampling and pre-treatment of proteins for reliable mass spectrometric analysis (MS).
Our aim is to contribute with research activities and innovation-based projects at the medicinal chemistry frontier.
In our research group we investigate innate immune responses against viral disease and how immuno-stimulants can be used to enhance the effect of vaccines against disease in finfish aquaculture. We also have an interest in how diet influence the immune system and inflammation status in fish tissues.